MALT LYMPHOMA
Clinical trials for MALT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MALT LYMPHOMA trials appear
Sign up with your email to follow new studies for MALT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to tame lymphoma with less radiation damage
Disease control Recruiting nowThis study tests a two-step treatment for adults with early-stage MALT lymphoma. First, patients get a very low dose of radiation over two days, then take a daily pill called orelabrutinib for up to 6 months. The goal is to control the cancer while avoiding the long-term side eff…
Matched conditions: MALT LYMPHOMA
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug SGR-1505 enters human testing for blood cancers
Disease control Recruiting nowThis early-phase trial tests a new drug, SGR-1505, in about 98 adults with various B-cell blood cancers (like lymphoma or leukemia). The main goals are to check safety, find the best dose, and see how the body handles the drug. Participants must have a confirmed diagnosis and be …
Matched conditions: MALT LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC